Skip to content

Fortrea Holdings Inc. FTRE Additional Paid-In Capital

Additional Paid-In Capital at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.97B-0.5%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$953.42M+7.5%
Septerna, Inc. logo
Septerna, Inc.SEPN
$554.87M+2.8%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$1.26B+2.1%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$1.96B+4.5%
NeoGenomics logo
NeoGenomicsNEO
$1.28B+3.2%

Other financials

Income statement

See full
Revenue$636.5M-2.3%
Gross profit$123.6M+6.1%
Operating income-$3.4M+99.3%
Net income-$23.6M+95.8%
EPS (diluted)-$0.25+96.0%

Balance sheet

See full
Cash & equivalents$147.5M+45.2%
Total debt$1.1B-13.1%
Total equity$525.9M-38.8%
Total assets$2.7B-14.0%

Cash flow

See full
Operating cash flow-$17.0M+86.3%
CapEx$8.0M+176%
Free cash flow-$25.0M+80.3%

Valuation

See full
Market cap$1.61B+29.3%

Profitability

See full
Gross margin18.9%-1.3pp
Operating margin-13.1%-4.1pp
Net margin-16.5%-5.0pp
FCF margin5.8%+1.7pp

Returns & leverage

See full
Return on equity-64.5%0.0pp
Debt / equity2.1×+0.6×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fortrea Holdings Inc.'s additional paid-in capital?
Fortrea Holdings Inc. (FTRE) reported additional paid-in capital of $2.13B in Q1 2026.
How has Fortrea Holdings Inc.'s additional paid-in capital changed year-over-year?
Fortrea Holdings Inc.'s additional paid-in capital increased by 3.5% year-over-year, from $2.06B to $2.13B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.